Todd Anderman is Chief Legal Officer of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 87,568 shares of OCUL, which is worth approximately $1.02 Million. The most recent transaction as insider was on Oct 08, 2025, when has been sold 11,132 shares (Common Stock) at a price of $12.34 per share, resulting in proceeds of $137,368. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 87.6K
11.28% 3M change
11.28% 12M change
Total Value Held $1.02 Million

Todd Anderman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 08 2025
SELL
Open market or private sale
$137,368 $12.34 p/Share
11,132 Reduced 11.28%
87,568 Common Stock
Oct 07 2024
BUY
Grant, award, or other acquisition
-
98,700 Added 50.0%
98,700 Common Stock
TA

Todd Anderman

Chief Legal Officer
Bedford, MA

Track Institutional and Insider Activities on OCUL

Follow OCULAR THERAPEUTIX, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUL shares.

Notify only if

Insider Trading

Get notified when an Ocular Therapeutix, Inc insider buys or sells OCUL shares.

Notify only if

News

Receive news related to OCULAR THERAPEUTIX, INC

Track Activities on OCUL